SAA1 and COVID-19: The appeal of SAA in investigating various inflammatory and infectious diseases, including COVID-19, is due to its ability to rapidly increase its concentration by more than 1000 times during the first 24-36 hours after the onset of tissue injury and subsequent inflammation.